ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,400, issued on Dec. 23, was assigned to CHIESI FARMACEUTICI S.P.A. (Parma, Italy).
"Method of preventing of systemic-to-pulmonary-artery shunt thrombosis" was invented by Thomas Diacovo (Larchmont, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to the use of cangrelor for the treatment and/or prevention of shunt thrombosis in patients suffering congenital heart diseases undergoing shunt surgery. The invention is also directed to the use of cangrelor for the treatment and/or prevention of stent thrombosis in pediatric patients undergoing stent implantation."
The patent was filed on Feb. 21, 2024, under Applicat...